A Randomized Phase III Trial of Capecitabine With or Without Irinotecan Driven by UGT1A1 in Neoadjuvant Chemoradiation of Locally Advanced Rectal Cancer
Phase of Trial: Phase III
Latest Information Update: 06 Jun 2017
At a glance
- Drugs Capecitabine (Primary) ; Irinotecan (Primary) ; Oxaliplatin
- Indications Adenocarcinoma; Rectal cancer
- Focus Registrational; Therapeutic Use
- Acronyms CinClare
- 06 Jun 2017 Trial design presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
- 11 Oct 2016 Trial design presented at the 41st European Society for Medical Oncology Congress.
- 26 Dec 2015 According to the ClinicalTrials.gov record, the treatment table (dosage) has been updated.